Quaker Chemical (NYSE:KWR) Given New $182.00 Price Target at Deutsche Bank Aktiengesellschaft

Quaker Chemical (NYSE:KWRFree Report) had its target price decreased by Deutsche Bank Aktiengesellschaft from $190.00 to $182.00 in a report issued on Monday morning,Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the specialty chemicals company’s stock.

KWR has been the topic of a number of other reports. StockNews.com raised Quaker Chemical from a “hold” rating to a “buy” rating in a research report on Tuesday, October 29th. Royal Bank of Canada lowered their price objective on Quaker Chemical from $220.00 to $195.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th.

Check Out Our Latest Research Report on Quaker Chemical

Quaker Chemical Price Performance

NYSE KWR opened at $169.75 on Monday. The business’s fifty day moving average is $162.92 and its 200 day moving average is $171.68. Quaker Chemical has a fifty-two week low of $151.31 and a fifty-two week high of $221.94. The company has a market capitalization of $3.02 billion, a PE ratio of 24.89, a price-to-earnings-growth ratio of 1.98 and a beta of 1.38. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.88 and a current ratio of 2.54.

Quaker Chemical (NYSE:KWRGet Free Report) last announced its quarterly earnings results on Thursday, October 31st. The specialty chemicals company reported $1.89 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.08 by ($0.19). The firm had revenue of $462.27 million during the quarter, compared to analysts’ expectations of $469.17 million. Quaker Chemical had a net margin of 6.58% and a return on equity of 10.10%. The firm’s revenue for the quarter was down 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.05 EPS. Sell-side analysts predict that Quaker Chemical will post 7.88 earnings per share for the current year.

Hedge Funds Weigh In On Quaker Chemical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KWR. Fidelis Capital Partners LLC purchased a new position in Quaker Chemical in the 1st quarter worth $25,000. First Pacific Financial acquired a new stake in shares of Quaker Chemical during the 2nd quarter valued at about $25,000. GAMMA Investing LLC boosted its holdings in Quaker Chemical by 105.3% in the 3rd quarter. GAMMA Investing LLC now owns 156 shares of the specialty chemicals company’s stock worth $26,000 after buying an additional 80 shares during the last quarter. Fifth Third Bancorp boosted its holdings in Quaker Chemical by 36.8% in the 2nd quarter. Fifth Third Bancorp now owns 286 shares of the specialty chemicals company’s stock worth $49,000 after buying an additional 77 shares during the last quarter. Finally, KBC Group NV boosted its holdings in Quaker Chemical by 50.9% in the 3rd quarter. KBC Group NV now owns 525 shares of the specialty chemicals company’s stock worth $88,000 after buying an additional 177 shares during the last quarter. Hedge funds and other institutional investors own 77.46% of the company’s stock.

About Quaker Chemical

(Get Free Report)

Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.

Further Reading

Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.